Virtus are working with Apollo Therapeutics on pre-clinical studies working towards the world’s first rhinovirus vaccine.
Virtus are working with Apollo Therapeutics on pre-clinical studies working towards the world’s first rhinovirus vaccine.
Our experience working with VirTus was terrific. They were easy to interact with, collaborative, and provided helpful advice and information at every turn throughout the clinical trial.BRENTON SCOTT, PRESIDENT AND COO, PULMOTECT, INC.Pulmotect, Inc.Virtus Respiratory...
Got any questions? Email info@virtus-rr.com or call us on 0207 554 5855
Want to find out more how we can help you develop the next block-buster medicine in asthma or COPD? Get in touch.